Ketalar

Ketamine, the active ingredient in Ketalar, is a dissociative anesthetic presented as an injectable solution for intramuscular and intravenous use. It is employed to induce general anesthesia, provide procedural sedation, and deliver analgesia in surgical and diagnostic settings.

GNH USA supplies Ketalar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, sourcing the product from EU manufacturers adhering to stringent quality standards. Our distribution network ensures timely delivery and regulatory compliance across multiple regions.

Ketamine acts on the central nervous system to produce dissociative anesthesia and analgesia, making it suitable for several clinical scenarios.

- Induction of general anesthesia: provides rapid, controllable unconsciousness for surgical procedures. - Procedural sedation: offers sedation and analgesia for diagnostic or minor surgical interventions. - Analgesia: delivers potent pain relief in peri‑operative settings and for severe acute pain.

Ketamine may cause a range of adverse reactions, ranging from mild to severe.

Common Side Effects: - Hypertension: transient increase in blood pressure. - Tachycardia: elevated heart rate. - Nausea: feeling of sickness. - Vomiting: expulsion of stomach contents. - Dizziness: sensation of light‑headedness. - Visual disturbances: blurred or altered vision.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort. - Laryngospasm: involuntary vocal cord closure. - Emergence delirium: agitation and confusion on waking. - Hallucinations: vivid sensory distortions. - Seizures: abnormal electrical brain activity. - Severe allergic reactions: rash, swelling, anaphylaxis.

Ketamine requires careful patient assessment and monitoring to minimize risks. - Cardiovascular monitoring: observe blood pressure and heart rate during administration. - Respiratory monitoring: ensure adequate ventilation and oxygenation. - Contraindications: avoid use in patients with known hypersensitivity to ketamine. - Psychiatric considerations: use cautiously in individuals with schizophrenia or severe mental illness. - Drug interactions: review concomitant medications for additive CNS effects. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Ketamine can interact with other agents, altering its safety profile.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates): may enhance sedation and respiratory depression. - MAO inhibitors: risk of hypertensive crisis. - Sympathomimetic agents (e.g., epinephrine): additive cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Alcohol: increased central nervous system effects. - Antihypertensives: possible attenuation of blood pressure control. - Anticholinergics: may exacerbate tachycardia. - Serotonergic drugs: potential for serotonin syndrome.